Moreover, the 36-month beta value for BDMD is -0.75.
The public float for BDMD is 13.46M and currently, short sellers hold a 0.56% of that float. On June 26, 2025, BDMD’s average trading volume was 66.96K shares.
BDMD) stock’s latest price update
The stock of Baird Medical Investment Holdings Limited (NASDAQ: BDMD) has decreased by -8.89 when compared to last closing price of 6.64. Despite this, the company has experienced a -6.20% fall in its stock price over the last five trading sessions. prnewswire.com reported 2025-05-19 that NEW YORK, May 19, 2025 /PRNewswire/ — Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) (“Baird Medical” or the “Company”), a global leader in minimally invasive Microwave Ablation (MWA) technology, is pleased to announce its participation in the 45th Annual Meeting of the American Association of Endocrine Surgeons (AAES), taking place from May 17-19, 2025, at the Baird Center in Milwaukee, Wisconsin.
BDMD’s Market Performance
Baird Medical Investment Holdings Limited (BDMD) has experienced a -6.20% fall in stock performance for the past week, with a 22.47% rise in the past month, and a 0.76% rise in the past quarter. The volatility ratio for the week is 12.89%, and the volatility levels for the past 30 days are at 17.62% for BDMD. The simple moving average for the last 20 days is 17.43% for BDMD stock, with a simple moving average of 16.30% for the last 200 days.
BDMD Trading at 14.38% from the 50-Day Moving Average
After a stumble in the market that brought BDMD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -55.25% of loss for the given period.
Stock Fundamentals for BDMD
Current profitability levels for the company are sitting at:
- 0.31 for the present operating margin
- 0.87 for the gross margin
The net margin for Baird Medical Investment Holdings Limited stands at 0.28. The total capital return value is set at 0.1. Equity return is now at value -25.39, with -14.19 for asset returns.
Based on Baird Medical Investment Holdings Limited (BDMD), the company’s capital structure generated 0.28 points at debt to capital in total, while cash flow to debt ratio is standing at -0.28.
Currently, EBITDA for the company is 12.85 million with net debt to EBITDA at 2.78. When we switch over and look at the enterprise to sales, we see a ratio of 17.06. The receivables turnover for the company is 0.38for trailing twelve months and the total asset turnover is 0.21. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.02.
Conclusion
To wrap up, the performance of Baird Medical Investment Holdings Limited (BDMD) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
